OR WAIT null SECS
April 18, 2019
The company passed a seven-day FDA surveillance GMP inspection and announced two upcoming manufacturing partnerships.
April 15, 2019
At INTERPHEX 2019, CEO Richard Johnson highlighted the importance of PDA’s new Asian business unit and outlined the organization’s plans. Data integrity guidance for manufacturing and quality systems will be published by the end of the year, as efforts move into big data and artificial intelligence.
April 05, 2019
The EU has announced that it has launched two WTO cases on unlawful import duties on ICT products and unlawful measures on pharmaceuticals, against India and Turkey, respectively.
April 03, 2019
In a keynote session at INTERPHEX 2019, experts will review and debate the issues and present potential solutions for contamination issues in aseptic manufacturing.
April 02, 2019
Supplier vetting and monitoring-plus comprehensive testing-ensure quality of raw materials.
March 07, 2019
Hetero Labs recalls losartan potassium tablets due to presence of N-Nitroso-N-methyl-4-aminobutyric acid.
December 12, 2018
FDA cites Zhejiang Huahai Pharmaceutical in valsartan impurity investigation.
October 02, 2018
Experts blame the recalls, not on cGMP failures, but on inadequate risk assessment of processes that can generate toxic impurities.
September 28, 2018
While food, shelter, and clothing are the primal essentials for life, hope-as embodied by modern medicine-has now become part of that human expectation.
June 01, 2018
The company’s new UV-1900 UV-VIS spectrophotometer incorporates features that improve usability, regulatory compliance, and performance.